Technology initially developed for the medical industry has been optimised for plant and animal nutrition. A number of trials have shown increased nutritional content through fortification, shelf life, increased nutrient use and a lower environmental footprint. The technology has moved from the laboratory to full production. Groundbreaking trials has shown interest from a number of growers and processors. This pioneering technology was initially developed to enrich the nutritional value of potatoes, in conjunction with the Agriculture and Horticulture Development Board (“AHDB”) which represents farmers.
Preliminary results not only showed a 20 per cent. increase in iron uptake by the tubers, but also an increase in yield and an approximate two-week reduction in the time to harvest. This patented technology has now been developed for use in the growing of other commercial crops, both in soil and hydroponically.
Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).
